Profiel
Johan Stein is currently a Director at Epicyt Pharma AB.
Previously, he worked as the Head of European Equities at Nordea Investment Management AB from 2003 to 2012 and as a Portfolio Manager at Alfred Berg Kapitalförvaltning AB from 2016 to 2020.
Actieve functies van Johan Stein
Bedrijven | Functie | Begin |
---|---|---|
Epicyt Pharma AB
Epicyt Pharma AB Pharmaceuticals: MajorHealth Technology Epicyt Pharma AB is a Swedish pharmaceutical research company that was founded in 2016 by Ville Wallenius and Lars Fändriks. The company is based in Mölndal, Sweden. Epicyt Pharma develops the drug candidate BAFA. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Johan Stein
Bedrijven | Functie | Einde |
---|---|---|
Alfred Berg Kapitalförvaltning AB
Alfred Berg Kapitalförvaltning AB Investment ManagersFinance Alfred Berg Asset Management AB (ABAM) is the Swedish asset management subsidiary of Alfred Berg Asset Management AB, ultimately held by BNP Paribas SA (XP: BNP, ADR: BNPQY) in France. The firm is based in Stockholm and manages assets for investment funds, charities, financial institutions, pension funds and individual investors. In combination with BNP Paribas Investment Partners products and services, they offer solutions across asset classes and investment styles and are the sole distributor of BNP Paribas Investment Partners investment products and services in the Nordic region. | Portefeuillebeheerder-Aandelen | 01-09-2020 |
Nordea Investment Management AB
Nordea Investment Management AB Investment ManagersFinance Nordea Investment Management AB (NIM) is the Swedish investment management subsidiary of Nordea Asset Management Holding AB, itself a subsidiary of Nordea Bank ABp (HEL: NDA-FI, ADR: NRBAY) in Finland. Founded in 1954 as Merita Nordbanken Investment Management, the firm became Nordea Investment Management AB in 2001 when the Nordea name, an abbreviation of Nordic ideas, replaced Unibank, Nordbanken, Merita and Christiania Bank in a joint renaming operation. Headquartered in Stockholm, NIM manages a range of Swedish funds including pension funds, hedge funds, Luxembourg-domiciled SICAVs and funds registered in other Nordic countries for institutional clients. | Head-Equity Investments | 01-01-2012 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Nordea Investment Management AB
Nordea Investment Management AB Investment ManagersFinance Nordea Investment Management AB (NIM) is the Swedish investment management subsidiary of Nordea Asset Management Holding AB, itself a subsidiary of Nordea Bank ABp (HEL: NDA-FI, ADR: NRBAY) in Finland. Founded in 1954 as Merita Nordbanken Investment Management, the firm became Nordea Investment Management AB in 2001 when the Nordea name, an abbreviation of Nordic ideas, replaced Unibank, Nordbanken, Merita and Christiania Bank in a joint renaming operation. Headquartered in Stockholm, NIM manages a range of Swedish funds including pension funds, hedge funds, Luxembourg-domiciled SICAVs and funds registered in other Nordic countries for institutional clients. | Finance |
Alfred Berg Kapitalförvaltning AB
Alfred Berg Kapitalförvaltning AB Investment ManagersFinance Alfred Berg Asset Management AB (ABAM) is the Swedish asset management subsidiary of Alfred Berg Asset Management AB, ultimately held by BNP Paribas SA (XP: BNP, ADR: BNPQY) in France. The firm is based in Stockholm and manages assets for investment funds, charities, financial institutions, pension funds and individual investors. In combination with BNP Paribas Investment Partners products and services, they offer solutions across asset classes and investment styles and are the sole distributor of BNP Paribas Investment Partners investment products and services in the Nordic region. | Finance |
Epicyt Pharma AB
Epicyt Pharma AB Pharmaceuticals: MajorHealth Technology Epicyt Pharma AB is a Swedish pharmaceutical research company that was founded in 2016 by Ville Wallenius and Lars Fändriks. The company is based in Mölndal, Sweden. Epicyt Pharma develops the drug candidate BAFA. | Health Technology |